cancer research

  • information about event
    -
    Virginia Commonwealth University
    Join two CTSA Program hubs and two NCI-designated cancer centers for a community and academic dialogue of trust and trustworthiness in research. Co-hosted by the VCU Wright Center for Clinical and Translational Research, the Duke Clinical & Translational Science Institute, the VCU Massey Cancer Center and the Duke Cancer Institute. Keynote speaker: Rueben Warren, Ph.D., Tuskegee University
  • Vitamin C, an essential dietary nutrient for humans, has been touted for its immune boosting properties for more than half a century. More recently, research has revealed its greater potential as a treatment for blood cancers. In her ongoing research, Miami CTSI Pilot Award recipient and Principal Investigator Luisa Cimmino, Ph.D., explores the potential of Vitamin C to combat blood cancers such as leukemia.

  • National Cancer Institute
    May is National Cancer Research Month, and Clinical and Translational Science Award (CTSA) Program hubs are on the forefront of cancer research. From genetic counseling to mining electronic health records, the CTSA Program is approaching cancer research from multiple directions, with the goal of getting treatments to patients more quickly. Click through the map below to see the contributions hubs
  • Dr. Megan Mendez Miller is interested in removing barriers to colorectal cancer screening in central Pennsylvania. Miller, a Penn State Health family doctor, is partnering with community health organizations for a program to increase screening. Penn State Clinical and Translational Science Institute invested through its pilot grant program to research how effective the program might be for use in
  • Frailty, which is characterized by weakness, fatigue and weight loss, is a common occurrence among patients with cancer and can impact their quality of life and survival. A recent study led by a KL2 Career Development scholar, funded by the University of Rochester Clinical and Translational Science Institute, links frailty to inflammation levels in the blood of women with breast cancer. Women with

  • Storytelling is one of the most effective ways to share our experiences and impart meaning onto our world. Through stories, we can connect with others in different levels, learn something new or feel inspired to explore new ideas. At the Institute of Translational Health Sciences (ITHS) we have an opportunity to do this by sharing our own stories of innovation, successes, research, new projects

  • The Oregon Clinical & Translational Clinical Research Institute (OCTRI) at Oregon Health & Science University (OHSU) funded three projects for their 2020 Biomedical Innovation Program drug discovery track. The funded research covers pancreatic cancer, prostate cancer, and SARS-CoV-2. This category of funding supports drug discovery platforms and early-stage therapeutic technology projects
  • Are two drugs better than one when it comes to treating B-cell acute lymphoblastic leukemia? Funding from the St. Baldrick’s Foundation will help a Penn State College of Medicine investigator answer that question. Dr. Chandrika Gowda, an associate professor of pediatrics and Four Diamonds researcher, received a $75,000 St. Baldrick’s Scholar Grant to continue work on a project that is exploring